This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
RLJ vs. OHI: Which Stock Is the Better Value Option?
by Zacks Equity Research
RLJ vs. OHI: Which Stock Is the Better Value Option?
Omega Healthcare Investors (OHI) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
The headline numbers for Omega Healthcare Investors (OHI) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Omega Healthcare Investors (OHI) Q4 FFO Beat Estimates
by Zacks Equity Research
Omega Healthcare Investors (OHI) delivered FFO and revenue surprises of 1.49% and 1.04%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
RLJ vs. OHI: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
RLJ vs. OHI: Which Stock Is the Better Value Option?
Gear Up for Omega Healthcare Investors (OHI) Q4 Earnings: Wall Street Estimates for Key Metrics
by Zacks Equity Research
Besides Wall Street's top -and-bottom-line estimates for Omega Healthcare Investors (OHI), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2023.
Should iShares Morningstar Small-Cap Value ETF (ISCV) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for ISCV
Omega Healthcare Investors (OHI) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for Omega Healthcare Investors (OHI) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
All You Need to Know About Omega Healthcare Investors (OHI) Rating Upgrade to Buy
by Zacks Equity Research
Omega Healthcare Investors (OHI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Welltower (WELL) Sees Robust Operating Trend, Raises View
by Zacks Equity Research
Welltower (WELL) amps up its 2023 normalized FFO per share outlook to $3.51-$3.60, backed by the continued strength in the seniors housing operating portfolio and accretive capital deployment activity.
Are Finance Stocks Lagging Enact Holdings (ACT) This Year?
by Zacks Equity Research
Here is how Enact Holdings, Inc. (ACT) and Omega Healthcare Investors (OHI) have performed compared to their sector so far this year.
Here's Why You Should Add Welltower (WELL) to Your Portfolio
by Zacks Equity Research
Welltower (WELL) is likely to benefit from a rebounding senior housing industry, its portfolio repositioning efforts and a solid balance sheet. However, high interest rates are concerning.
American Tower (AMT) Rides on Wireless Demand, Acquisitions
by Zacks Equity Research
American Tower (AMT) is well-poised to gain from the rising demand for wireless connectivity and its strategic acquisitions despite customer concentration woes and a high-interest-rate environment.
Ventas (VTR) Partners With Operators for Senior Housing Growth
by Zacks Equity Research
Ventas (VTR) teams up with expert operators to enhance the performance of 26 independent living communities.
Pebblebrook's (PEB) July Operating Results Meet Expectations
by Zacks Equity Research
Pebblebrook's (PEB) operating results for July match its expectations on continued demand recovery in the urban markets. It notes no material damage to its properties due to Tropical Storm Hilary.
Welltower (WELL) Picks Optima Living to Manage Seniors Communities
by Zacks Equity Research
In sync with its efforts to enhance operator diversification, Welltower (WELL) selects Optima Living to manage six seniors communities in Western Canada.
Ashford Hospitality (AHT) Updates on Key West Hotel Conversion
by Zacks Equity Research
Ashford Hospitality (AHT) notes that it is on track with its Crowne Plaza La Concha Hotel conversion and expects to benefit in terms of RevPAR from the move.
Are Finance Stocks Lagging Enact Holdings (ACT) This Year?
by Zacks Equity Research
Here is how Enact Holdings, Inc. (ACT) and Omega Healthcare Investors (OHI) have performed compared to their sector so far this year.
Iron Mountain (IRM) Shares Rally 17% YTD: Will the Trend Last?
by Zacks Equity Research
Strong cash flows in the storage and records management business and a focus on the data center business are upsides for Iron Mountain (IRM). An aggressive acquisition strategy supplements organic growth.
Equinix (EQIX) Shares Rally 15% YTD: Will the Trend Last?
by Zacks Equity Research
The data center business is thriving across geographies, and Equinix (EQIX) is well-poised to capitalize on this opportunity. Its recurring revenue model and strategic expansions are encouraging.
Is Invesco KBW Premium Yield Equity REIT ETF (KBWY) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for KBWY
Is Iron Mountain (IRM) Stock Apt for Your Portfolio Now?
by Zacks Equity Research
Strong cash flows in storage and the records management business and a focus on the data center business are upsides for Iron Mountain (IRM).
Here's Why You Should Retain Vornado Realty (VNO) Stock Now
by Zacks Equity Research
Vornado Realty's (VNO) properties are poised to attract tenants due to the solid desire for top-notch assets. Its repositioning efforts bode well, though high interest rates remain a key concern.
Digital Realty (DLR) Up 24% in 3 Months: Will the Trend Last?
by Zacks Equity Research
Robust data-center demand, strategic expansions and solid balance-sheet strength are likely to continue driving Digital Realty's (DLR) stock. However, high interest rates are concerning.
Omega Healthcare Investors (OHI) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for Omega Healthcare Investors (OHI) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Omega Healthcare Investors (OHI) Beats Q2 FFO and Revenue Estimates
by Zacks Equity Research
Omega Healthcare Investors (OHI) delivered FFO and revenue surprises of 7.25% and 4.87%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?